Company Directory - Colossal Biosciences
Company Details - Colossal Biosciences
Colossal Biosciences
WebsiteDallas, United States
Colossal Biosciences is a Dallas-based company focused on genomic projects, including de-extinction and genetic modification of animals. Their innovative approaches aim to resurrect extinct species and use advanced biotechnologies for conservation.
CCI Score
CCI Score: Colossal Biosciences
44.45
-0.01%
Latest Event
Breakthrough in De-extinction: Dire Wolf Pups Engineered
Colossal Biosciences announced the successful genetic engineering of three dire wolf pups, marking a pioneering de-extinction effort. The project involved modifying 20 genes of the gray wolf using DNA extracted from a dire wolf specimen, with the aim of studying behavioral traits and conservation applications.
Take Action
So what can you do? Support Colossal by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
DISSENTER
Colossal Biosciences is currently rated as a Dissenter.
Latest Events
- APR082025
Colossal Biosciences announced the successful genetic engineering of three dire wolf pups, marking a pioneering de-extinction effort. The project involved modifying 20 genes of the gray wolf using DNA extracted from a dire wolf specimen, with the aim of studying behavioral traits and conservation applications.
- APR082025
Colossal Biosciences announced the birth of genetically engineered dire wolf pups using advanced CRISPR and cloning techniques as part of its de-extinction and conservation efforts. The project, which involved extensive genome editing and collaboration with USDA and certification by the American Humane Society, aims to revive species long extinct and bolster conservation initiatives.
- APR072025
Colossal Biosciences announced the world’s first de-extinction of the dire wolf through advanced gene editing and cloning technology. The breakthrough, which also includes the birth of red wolves, underscores the company’s commitment to ethical conservation practices, indigenous collaboration, and innovative approaches to combat biodiversity loss.
+40
Public and Political Behavior
April 8
The announcement reflects positive public engagement through collaboration with indigenous communities and conservation organizations, reinforcing values of social responsibility and anti-authoritarian stewardship.
Colossal Announces World’s First De-Extinction: Birth of Dire Wolves
+50
Business Practices and Ethical Responsibility
April 8
Colossal Biosciences exhibits strong ethical responsibility by advancing innovative and humane conservation technologies, ensuring high standards in animal welfare and environmental stewardship.
Colossal Announces World’s First De-Extinction: Birth of Dire Wolves
+60
Technology and Services Impact
April 8
The breakthrough employs cutting‐edge CRISPR and cloning technologies to achieve de-extinction, setting a new standard in biotechnology that supports conservation and scientific progress.
Colossal Announces World’s First De-Extinction: Birth of Dire Wolves
+20
Economic and Structural Influence
April 8
The project, while primarily a scientific and conservation breakthrough, has structural economic benefits by paving the way for sustainable conservation practices and long-term ecological restoration.
Colossal Announces World’s First De-Extinction: Birth of Dire Wolves
Alternatives

Corporation
63.97

Corporation
11.46
Corporation
0.00
Corporation
0.00

Corporation
0.00

Corporation
0.00
Corporation
-54.90
Corporation
0.00

Corporation
0.00

Corporation
0.00
Industries
- 325414
- Biological Product (except Diagnostic) Manufacturing
- 541715
- Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- 541990
- All Other Professional, Scientific, and Technical Services